Diabetic control and coronary artery bypass: effect on short-term outcomes

Stephen Strahan1, Ryan M Harvey, Andrew Campbell-Lloyd

  • 1Department of Cardiac Surgery, Princesses Alexandria Hospital, Brisbane, Queensland, Australia.

Insights

Preoperative glycemic control and treatment type did not impact short-term outcomes for diabetic patients undergoing coronary artery bypass grafting. Strict perioperative glucose management may explain these findings.

Area of Science:

  • Cardiology
  • Diabetology
  • Surgical Outcomes

Background:

  • Diabetic patients represent a significant portion of individuals undergoing coronary artery bypass grafting (CABG).
  • Preoperative glycemic control is a critical factor influencing surgical outcomes in diabetic patients.
  • Understanding the impact of glycemic control on morbidity and mortality in CABG is essential for optimizing patient care.

Purpose of the Study:

  • To investigate the association between preoperative glycemic control and hospital morbidity and mortality.
  • To evaluate the effect of different diabetic treatment modalities on outcomes in patients undergoing primary CABG.
  • To compare outcomes between diabetic patients and a non-diabetic control group.

Main Methods:

  • A retrospective analysis of prospectively collected data from 3857 patients undergoing primary CABG.
  • Categorization of 1109 diabetic patients based on treatment (diet, oral hypoglycemic agents, insulin) and glycemic control (hemoglobin A1c <7% vs. ≥7%).
  • Comparison of complication rates between diabetic subgroups and 2748 non-diabetic controls.

Main Results:

  • Diabetic patients exhibited higher prevalence of preoperative risk factors like hypertension, hyperlipidemia, renal failure, peripheral vascular disease, and COPD.
  • No significant difference in major complications between diabetic and control groups (p=0.33).
  • Minor complications were less frequent in diabetic patients (p=0.03), with no significant differences among treatment or glycemic control subgroups.

Conclusions:

  • Preoperative glycemic control and treatment type did not significantly affect short-term morbidity or mortality in diabetic patients undergoing primary CABG.
  • Strict protocol-driven glycemic control during the perioperative period may mitigate the impact of preoperative glycemic status.
  • These findings suggest that standardized perioperative glucose management is crucial for diabetic patients undergoing cardiac surgery.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
35
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
630
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55